[go: up one dir, main page]

ES2058292T3 - Derivados de indol. - Google Patents

Derivados de indol.

Info

Publication number
ES2058292T3
ES2058292T3 ES88307499T ES88307499T ES2058292T3 ES 2058292 T3 ES2058292 T3 ES 2058292T3 ES 88307499 T ES88307499 T ES 88307499T ES 88307499 T ES88307499 T ES 88307499T ES 2058292 T3 ES2058292 T3 ES 2058292T3
Authority
ES
Spain
Prior art keywords
alkyl
compounds
indol
derivatives
headache
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88307499T
Other languages
English (en)
Inventor
Alexander William Oxford
Darko Butina
Martin Richard Owen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878719167A external-priority patent/GB8719167D0/en
Priority claimed from GB888814002A external-priority patent/GB8814002D0/en
Priority claimed from GB888814481A external-priority patent/GB8814481D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2058292T3 publication Critical patent/ES2058292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPUESTOS DE FORMULA GENERAL(I) DONDE R1 REPRESENTA H O C1-6 ALQUILO, R2 ES H O C1-6 ALQUILO, R3 ES H, R4 ES H O C1-3 ALQUILO, Y SUS SALES Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES ( POR EJEMPLO HIDRATOS). LOS COMPUESTOS SON INDICADOS COMO UTILES PARA EL TRATAMIENTO DE MIGRAÑA, DOLOR DE CABEZA, HEMICRANIA PAROXISMICA CRONICA Y DOLOR DE CABEZA ASOCIADO CON ALTERACIONES VASCULARES. PROCESOS Y COMPUESTOS INTERMEDIOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES88307499T 1987-08-13 1988-08-12 Derivados de indol. Expired - Lifetime ES2058292T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878719167A GB8719167D0 (en) 1987-08-13 1987-08-13 Chemical compounds
GB888814002A GB8814002D0 (en) 1988-06-14 1988-06-14 Chemical compounds
GB888814481A GB8814481D0 (en) 1988-06-17 1988-06-17 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2058292T3 true ES2058292T3 (es) 1994-11-01

Family

ID=27263551

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88307499T Expired - Lifetime ES2058292T3 (es) 1987-08-13 1988-08-12 Derivados de indol.

Country Status (28)

Country Link
US (1) US4997841A (es)
EP (1) EP0303507B1 (es)
JP (1) JPH0633252B2 (es)
KR (1) KR0131327B1 (es)
AT (1) ATE92057T1 (es)
AU (1) AU611469B2 (es)
CA (1) CA1310968C (es)
CY (1) CY1728A (es)
CZ (1) CZ404291A3 (es)
DE (2) DE3882614T2 (es)
DK (1) DK172696B1 (es)
ES (1) ES2058292T3 (es)
FI (1) FI92397C (es)
GB (1) GB2208646B (es)
HK (1) HK86793A (es)
HU (1) HU211576A9 (es)
IE (1) IE61488B1 (es)
IL (1) IL87437A0 (es)
LU (1) LU90160I2 (es)
LV (1) LV5736B4 (es)
NL (1) NL970035I2 (es)
NO (2) NO174052C (es)
NZ (1) NZ225820A (es)
PH (1) PH24976A (es)
PT (1) PT88255B (es)
SG (1) SG65393G (es)
SK (1) SK281495B6 (es)
UY (1) UY23657A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds
DK0486666T3 (da) * 1990-06-07 1998-03-30 Zeneca Ltd Terapeutisk heterocykliske forbindelser
DK152090D0 (da) * 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
TW222631B (es) * 1991-07-15 1994-04-21 Duphar Int Res
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
JPH08501287A (ja) * 1992-08-05 1996-02-13 ジョン・ワイス・アンド・ブラザー・リミテッド アミド誘導体
GB9320115D0 (en) * 1993-09-29 1993-11-17 Glaxo Group Ltd Process
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
FR2731224B1 (fr) * 1995-03-02 1997-05-30 Pf Medicament Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments
FR2731222A1 (fr) * 1995-03-02 1996-09-06 Pf Medicament Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
PL322843A1 (en) * 1995-03-20 1998-02-16 Lilly Co Eli 5-substituted 3-91,2,3,6-tetrahydropyridin-4-yl)- and 3-9piperydin-4-4-yl0-1h-indoles nevel 5-htif natagonists
WO1997033579A1 (en) * 1996-03-13 1997-09-18 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
AR013669A1 (es) * 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
NZ523436A (en) * 2000-07-21 2004-07-30 H Indole derivatives useful for the treatment of CNS discorders
WO2002044159A2 (en) * 2000-11-29 2002-06-06 Eli Lilly And Company 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20070065463A1 (en) 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
US20060110328A1 (en) * 2004-11-24 2006-05-25 Cagle Gerald D Method of delivering nasal spray
AU2007310949A1 (en) * 2006-10-19 2008-04-24 Auspex Pharmaceuticals, Inc. Substituted indoles
WO2008056378A2 (en) * 2006-11-09 2008-05-15 Natco Pharma Limited Novel process for the preparation of naratriptan hydrochloride
WO2008072257A2 (en) * 2006-12-12 2008-06-19 Ind-Swift Laboratories Limited Process for the preparation of indole derivatives
WO2009016466A2 (en) * 2007-07-30 2009-02-05 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of naratriptan hydrochloride
WO2009118753A2 (en) * 2008-03-07 2009-10-01 Usv Limited Process for preparation of naratriptan hydrochloride
JP2011526889A (ja) 2008-06-30 2011-10-20 アフギン ファーマ，エルエルシー 局所局部的神経作用療法
WO2010004580A2 (en) * 2008-07-11 2010-01-14 Ind-Swift Laboratories Limited Process for preparing indole derivatives
WO2010084507A2 (en) * 2008-07-15 2010-07-29 Sun Pharmaceutical Industries Ltd. Process for the preparation of n-methyl-2-[3-(1-methyl-4-piperidyl)-1h-indol-5-yl]-ethanesulfonamide and its acid addition salts
EP2467373B1 (en) 2009-08-20 2013-10-02 Cipla Limited A process for the synthesis of naratriptan
CN102276581B (zh) * 2011-08-05 2013-06-12 上海师范大学 N-取代四氢吡啶连吲哚类化合物及其制备方法及应用
HK1248564A1 (zh) 2015-03-02 2018-10-19 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
FR2421899A1 (fr) * 1978-01-16 1979-11-02 Roussel Uclaf Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
DE3419935A1 (de) * 1984-05-28 1985-11-28 Merck Patent Gmbh, 6100 Darmstadt Verwendung von hydroxyindolderivaten bei der senkung des blutdrucks
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
GB2168973B (en) * 1984-12-04 1988-02-03 Glaxo Group Ltd Indole derivatives
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
GB2208646B (en) 1991-06-26
DK455488A (da) 1989-02-14
DK172696B1 (da) 1999-05-31
DE19775082I2 (de) 2006-04-27
JPH0633252B2 (ja) 1994-05-02
GB8819200D0 (en) 1988-09-14
ATE92057T1 (de) 1993-08-15
KR0131327B1 (en) 1998-04-17
IL87437A0 (en) 1989-01-31
NL970035I2 (nl) 1998-01-05
NO883587D0 (no) 1988-08-12
HK86793A (en) 1993-08-27
FI883744L (fi) 1989-02-14
HU211576A9 (en) 1995-12-28
NO1998008I1 (no) 1998-02-05
PH24976A (en) 1990-12-26
US4997841A (en) 1991-03-05
LV5736B4 (lv) 1997-06-20
CZ404291A3 (en) 1993-04-14
FI883744A0 (fi) 1988-08-12
FI92397C (fi) 1994-11-10
IE61488B1 (en) 1994-11-02
NO174052C (no) 1994-03-09
CA1310968C (en) 1992-12-01
NZ225820A (en) 1990-09-26
SK281495B6 (sk) 2001-04-09
SK404291A3 (en) 2000-09-12
NL970035I1 (nl) 1997-11-03
KR890003731A (ko) 1989-04-17
SG65393G (en) 1993-08-06
GB2208646A (en) 1989-04-12
EP0303507B1 (en) 1993-07-28
UY23657A1 (es) 1994-02-25
AU611469B2 (en) 1991-06-13
JPH01207288A (ja) 1989-08-21
CY1728A (en) 1994-05-06
EP0303507A3 (en) 1990-09-19
DK455488D0 (da) 1988-08-12
LU90160I2 (fr) 1998-01-14
EP0303507A2 (en) 1989-02-15
PT88255A (pt) 1989-06-30
NO883587L (no) 1989-02-14
PT88255B (pt) 1995-03-01
NO174052B (no) 1993-11-29
LV5736A4 (lv) 1996-06-20
IE882477L (en) 1989-02-13
DE3882614D1 (de) 1993-09-02
DE3882614T2 (de) 1993-11-18
FI92397B (fi) 1994-07-29
AU2069288A (en) 1989-02-16

Similar Documents

Publication Publication Date Title
ES2058292T3 (es) Derivados de indol.
DK391289D0 (da) Indolderivater
MX9300031A (es) Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
PT83725B (pt) Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem
MX9304467A (es) Nuevos derivados fosfonados de ariletanolaminas, procedimiento para su preparacion y composiciones farmaceuticas y veterinarias que los contienen.
DK226285A (da) Beta-lactamforbindelser, deres fremstilling og anvendelse som laegemidler eller vaekstfremmende midler til dyr samt mellemprodukter til fremstillingen
FI822099A0 (fi) Maettade aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel
MX9300008A (es) Nucleosidos terapeuticos.
ES453501A1 (es) Un procedimiento para la preparacion de nuevos derivados n- metilenicos de tienamicina.
MX9204220A (es) Bencimidazoles.
MY103509A (en) Indole derivatives.
ES2099004B1 (es) Nuevos antifungicos activos por via oral.
AR004696A1 (es) Derivados de amidina e isotiourea, procedimientos para su preparacion, intermediarios nuevos utiles en dicho procedimiento, composiciones que loscontienen, su uso en terapia y metodos de tratamiento que comprenden dicho compuesto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 303507

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Spc suppl protection certif: C9800032

Filing date: 19981027

SPCG Supplementary protection certificate granted

Free format text: NARATRIPTAN (NARAMIG)

Spc suppl protection certif: C9800032

Filing date: 19981027

Expiry date: 20120310